App

The advantage of

Neuropathy Early Detection

SUDOSCAN : An innovative device for early detection and follow-up of Autonomic and Small Fiber Neuropathy.

More information

App

The advantage of

Neuropathy Early Detection

SUDOSCAN : An innovative device for early detection and follow-up of Autonomic and Small Fiber Neuropathy.

More information

About Sudoscan

SUDOSCAN offers a stimulation of the sweat glands that assess small nerve fibers

Diabetes

SUDOSCAN provides a better management of diabetes complications such as neuropathies to prevent diabetic foot.

Neurology

SUDOSCAN has demonstrated its efficacy in painful neuropathies, transthyretin amyloidosis, Sjogren’s Syndrome, Hepatitis C, Fabry disease….

Oncology

In oncology, SUDOSCAN has demonstrated its utility to quantify chemotherapy induced polyneuropathy (CIPN).

Follow-up

SUDOSCAN allows the physician to follow patient outcomes over time and assess the progression of neuropathy and the impact of medications.

Discover Sudoscan

BY IMPETO MEDICAL

An innovative device

SUDOSCAN is a test that provides an accurate evaluation of sweat function. The test focuses on small nerve fibers within the peripheral nervous system innervating the sweat glands.

The device consists of a computer and 4 electrodes on which patients place their hands and bare feet. In less than 3 minutes, SUDOSCAN offers a stimulation of the sweat glands that assess small nerve fibers (C fibers).

Simple results obtained in 3 minutes

The results are displayed automatically.
If the score is high, this indicates no sign of sudomotor dysfunction and no autonomic neuropathy. If the score is low, this indicates a sudomotor dysfunction and a neuropathy.

Sudoscan Technology

BY IMPETO MEDICAL

SUDOSCAN tests sweat gland function by applying a small direct current to both hand and foot sensor plates. At a low voltage, the stratum corneum acts as a capacitor, leaving the sweat ducts as the only channel for the transmission of Cl- ions.
SUDOSCAN provides a quantitative measure of chloride conductance (measured in microsiemens) and its results serve as a biomarker to assess sweat gland function in relation to sweat gland innervation.

The process

The patient is asked to put his hands and feet on large electrodes
A small electric tension is applied to the surface to stimulate the sweat glands
The results of the response to this stimulation are expressed as :
1. Electrochemical Skin Conductance for SUDOSCAN, indicating the presence and severity of the small fiber peripheral autonomic neuropathies;
2. Percentage of risk for EZSCAN indicating a risk to develop diabetes.

Why should you use Sudoscan ?

BY IMPETO MEDICAL

Diabetes

Early detection and follow-up of neuropathic patients to prevent diabetic foot and to improve the diabetes management

Neurology

Unique technology quick, simple, quantitative to assess Small fiber complementary to Electromyogram (large fibers). May lead to an etiology and its appropriate treatment

Oncology

Allows a quantitative assessment of the neuropathy chemotherapy-induced for an informed decision

Clinical Evidence for Sudoscan

BY IMPETO MEDICAL

SUDOSCAN is becoming a reference test in many countries :

Included the European Network for TTR-FAP Amyloidosis,
the German guidelines for Diabetes management,
the Latin America Diabetes association
and more..

Commercialized worldwide with more than 3000 devices sold.
CE certified Cleared for use by the US FDA, Registered and distributed in 34 countries.
=> Discover Sudoscan Publications

Sudoscan benefits

BY IMPETO MEDICAL

FAST

No patient preparation
Results in 3 minutes
Easy-to-read critical data points to help physicians reach a diagnosis

SECURE

Non-invasive
No fasting
Easy to operate
CE and FDA approvals

ACCURATE

Reproducible quantitative results
Independent from environmental conditions
Backed by evidence-based research
150 peer-reviewed journals publications

Latest news

Events

Sudoscan au congrès SFD de Montpellier du 21 au 24 mars 2023

March 1, 2023 No Comments

Events

Webinar: Early detection of Peripheral Neuropathy in Prediabetes and Diabetes to improve patient management – March 17th 2023

February 10, 2023 No Comments

Scientific publications

Sudoscan and Cardiovascular outcomes in Hemodialysis

Cardiac neuropathy

Sudoscan and Cardiovascular outcomes in Hemodialysis

February 28, 2023 No Comments

About Impeto Medical

Our Mission

Impeto Medical is a medical device company created in June 2005 part of WITHINGS company. Its corporate headquarters are located close to Paris, France. The company is also present in San Diego, CA, USA and in Beijing, China.
Our goal is to provide the medical community with screening tests to face epidemically spreading metabolic disorders and their complications.
By providing less invasive, faster and less costly procedures, we enable physicians to screen larger patient populations and to detect diseases complications earlier.
We build value for our investors through constant innovation based on clinical research as well as focus on priority medical issues.

Patents

The SUDOCAN® device is covered by the following patents:

“Electrophysiological analysis system and method” (US Patent No. US 8965497B2, European Patent No. EP 1898783B1),
“Electrophysiological analysis system” (US Patent No. US 8655443B2, European Patent No. EP 2124736B1),
“Assessment of sudomotor function for peripheral diabetic neuropathy evaluation” (US Patent No. US 8934954B2)
“Improved electrophysiological analysis system” (US Patent No. US 9636036B2, European Patent No. EP 2890294B1).

CERTIFICATION SYSTEM

ISO 13485:20 16

Promotional Communication. The medical devices SUDOSCAN & EZSCAN are regulated health products under the CE certification, Class IIa, according to the European Medical Device directive – SGS Belgium, notified body 1639. The test allows screening and monitoring of peripheral autonomic neuropathies. It can be performed in diabetic patients or in patients suffering from neurological diseases involving small fibers damage. As with any diagnostic test, its results must be interpreted in a global context including the clinic and other examinations performed. Please read the user manual instructions carefully. Contact our office for more information. Last update: 2021/01/12